27 related articles for article (PubMed ID: 12522677)
1. Focused Delivery of Chemotherapy to Augment Surgical Management of Brain Tumors.
Mehkri Y; Woodford S; Pierre K; Dagra A; Hernandez J; Reza Hosseini Siyanaki M; Azab M; Lucke-Wold B
Curr Oncol; 2022 Nov; 29(11):8846-8861. PubMed ID: 36421349
[TBL] [Abstract][Full Text] [Related]
2. A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art.
Pinkiewicz M; Pinkiewicz M; Walecki J; Zawadzki M
Front Oncol; 2022; 12():950167. PubMed ID: 36212394
[TBL] [Abstract][Full Text] [Related]
3. Anti-vascular endothelial growth factor in glioblastoma: a systematic review and meta-analysis.
Xiao Q; Yang S; Ding G; Luo M
Neurol Sci; 2018 Dec; 39(12):2021-2031. PubMed ID: 30327956
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.
Filippini G; Falcone C; Boiardi A; Broggi G; Bruzzone MG; Caldiroli D; Farina R; Farinotti M; Fariselli L; Finocchiaro G; Giombini S; Pollo B; Savoiardo M; Solero CL; Valsecchi MG;
Neuro Oncol; 2008 Feb; 10(1):79-87. PubMed ID: 17993634
[TBL] [Abstract][Full Text] [Related]
5. ACNU-cisplatin continuous infusion chemotherapy as salvage therapy for recurrent glioblastomas: phase II study.
Gwak HS; Youn SM; Kwon AH; Lee SH; Kim JH; Rhee CH
J Neurooncol; 2005 Nov; 75(2):173-80. PubMed ID: 16132508
[TBL] [Abstract][Full Text] [Related]
6. The role of intra-arterial chemotherapy as an adjuvant treatment for glioblastoma.
Theodotou C; Shah AH; Hayes S; Bregy A; Johnson JN; Aziz-Sultan MA; Komotar RJ
Br J Neurosurg; 2014 Aug; 28(4):438-46. PubMed ID: 24432794
[TBL] [Abstract][Full Text] [Related]
7. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
8. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
[TBL] [Abstract][Full Text] [Related]
9. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394.
Grossman SA; O'Neill A; Grunnet M; Mehta M; Pearlman JL; Wagner H; Gilbert M; Newton HB; Hellman R;
J Clin Oncol; 2003 Apr; 21(8):1485-91. PubMed ID: 12697871
[TBL] [Abstract][Full Text] [Related]
10. A randomized phase III study: comparison between intravenous and intraarterial ACNU administration in newly diagnosed primary glioblastomas.
Imbesi F; Marchioni E; Benericetti E; Zappoli F; Galli A; Corato M; Ceroni M
Anticancer Res; 2006; 26(1B):553-8. PubMed ID: 16739319
[TBL] [Abstract][Full Text] [Related]
11. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial ACNU and carboplatin versus intravenous chemotherapy with cisplatin and BCNU in newly diagnosed patients with glioblastoma.
Silvani A; Eoli M; Salmaggi A; Erbetta A; Fariselli L; Boiardi A
Neurol Sci; 2002 Dec; 23(5):219-24. PubMed ID: 12522677
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of malignant gliomas: studies of the BTCG.
Shapiro WR
Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
